I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Sa, A.
27496
results:
Articles (Online) X
Search for persons
X
Languages
german (55)
english (20748)
more...
portuguese (281)
french (42)
italian (54)
spanish (38)
less...
Sorted by: Relevance
Sorted by: Year
?
1
203P Real-world treatment patterns in patients with HER2+ u..:
Barrios, C.H.
;
Lee, S.C.
;
Chung, W-P.
...
ESMO Open. 9 (2024) - p. 103225 , 2024
Link:
https://doi.org/10.1016/..
?
2
181O Interim analysis (IA) of the atezolizumab (atezo) + sa..:
Schmid, P.
;
Loi, S.
;
De la Cruz Merino, L.
...
ESMO Open. 9 (2024) - p. 103203 , 2024
Link:
https://doi.org/10.1016/..
?
3
185P Safety, tolerability, and antitumor activity of trastu..:
Anders, C.
;
Loi, S.
;
Hamilton, E.P.
...
ESMO Open. 9 (2024) - p. 103207 , 2024
Link:
https://doi.org/10.1016/..
?
4
401P Vibostolimab coformulated with pembrolizumab (vibo/pem..:
Hsu, C-H.
;
Dziadziuszko, R.
;
Abreo, D.A. Gomez
...
Annals of Oncology. 35 (2024) - p. S163-S164 , 2024
Link:
https://doi.org/10.1016/..
?
5
198P Pembrolizumab plus olaparib vs pembrolizumab plus chem..:
Cussac, A. Llombart
;
Rugo, H.S.
;
Robson, M.E.
...
ESMO Open. 9 (2024) - p. 103220 , 2024
Link:
https://doi.org/10.1016/..
?
6
LBA2 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT)..:
Jhaveri, K.
;
Bardia, A.
;
Im, S-A.
...
ESMO Open. 9 (2024) - p. 103479 , 2024
Link:
https://doi.org/10.1016/..
?
7
180O IMpassion132 double-blind randomised phase III trial o..:
Dent, R.A.
;
André, F.
;
Gonçalves, A.
...
ESMO Open. 9 (2024) - p. 103202 , 2024
Link:
https://doi.org/10.1016/..
?
8
114P Fixed-dose combination of pertuzumab and trastuzumab f..:
Jackisch, C.
;
Im, S-A.
;
Mattar, A.
...
ESMO Open. 9 (2024) - p. 103102 , 2024
Link:
https://doi.org/10.1016/..
?
9
188P A health-related quality-of-life (HRQoL) analysis from..:
Ueno, N.T.
;
Cottone, F.
;
Dunton, K.
...
ESMO Open. 9 (2024) - p. 103210 , 2024
Link:
https://doi.org/10.1016/..
?
10
Clinical and Sociodemographic Characteristics of Patients D..:
Kaya, Kadir
;
An, sa
Annals of Medical Research. 31 (2024) 4 - p. 285 , 2024
Link:
https://doi.org/10.5455/..
?
11
261TiP TROPION-Breast05: Phase (Ph) III study of datopotama..:
Schmid, P.
;
Oliveira, M.
;
O'Shaughnessy, J.
...
ESMO Open. 9 (2024) - p. 103282 , 2024
Link:
https://doi.org/10.1016/..
?
12
Could a high epicardial adipose tissue volume increase the ..:
Temtem, M
;
Mendonca, M I
;
Sousa, J A
...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
13
PSRC1 rs599839 G allele may promote protection from coronar..:
Sousa, F
;
Mendonca, M
;
Sa, D
...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
14
Genetic risk score and epicardial adipose tissue: the new t..:
Temtem, M
;
Mendonca, M I
;
Sousa, J A
...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
15
Differences in the clinical course, laboratory and radiolog..:
zsoy, Hilal
;
nal, Serhat
;
l, sa
.
Annals of Medical Research. , 2023
Link:
https://doi.org/10.5455/..
1-15